Biotechnology News

October 2, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced the Company will be participating at the Surfaces in Biomaterials Foundation’s 24th Annual BioInterface Conference 2014,...

October 2, 2014

WASHINGTON--(BUSINESS WIRE)--BIO President and CEO James C. Greenwood congratulates India’s new Prime Minister, Narendra Modi on his successful first official visit to the United States.

October 2, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth to Sponsor Turning the Tide Against Cancer 2014 National Conference

October 2, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm introduces a Single-Cell Whole Exome Sequencing workflow for its C1 Single-Cell Auto Prep System.

October 2, 2014

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions today announced that it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag™ Antibody-Drug Conjugate (ADC) technology platform.

October 2, 2014

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Three months ago Manhattan Scientifics (OTCQB: MHTX) announced the delivery of its 1st breakthrough cancer measurement instrument to M.D. Anderson Cancer Center in Houston. The Company's technology uses iron...

October 2, 2014

MIDLAND, Mich.--(BUSINESS WIRE)--The Dow Chemical Company (NYSE: DOW) today announced several updates regarding divestiture and portfolio management actions – demonstrating the Company’s commitment to previously established targets and its...

October 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its investigational cancer medicine, AP26113, has received Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the...

October 2, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has earned a $60 million milestone payment from Novartis related to reimbursement of Jakavi® (ruxolitinib) in Europe. Incyte will record this amount as...

October 2, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SAFEBRIDGE® CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, announced that SABRE Health & Safety, LLC ("SABRE") in Easton, Pennsylvania has joined SafeBridge as of...

October 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, developing treatment for influenza, announced $30 million Series B financing w/ new investors Merck Research Labs Venture Fund, Vertex Venture Holdings Ltd. and Temasek & existing investors.

October 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics announced top-line results from a Phase 2 study of its lead drug candidate, EBI-005, in patients with moderate to severe allergic conjunctivitis.

October 2, 2014

STOCKHOLM--(BUSINESS WIRE)--Stresscompany offers evidence-based self-help tools through the internet that can improve mental health problems where stress is often a key factor. Following its listing on NASDAQ OMX First North, the company’s first...

October 2, 2014

LONDON--(BUSINESS WIRE)--DNA Electronics (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, announces today that its founder, Chairman and CEO Professor Chris...

October 2, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Susheel Surpal will step down as Chief Financial Officer of Ipsen as of 31st October 2014 to pursue new opportunities. The company will communicate...

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it has secured a $31 million term loan facility from Silicon Valley Bank. Under the loan facility, the company...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash transaction for approximately $8.5 million.

October 1, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering...

October 1, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2014 after market close on Thursday October 30, 2014. The company will hold a conference call on...

October 1, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence

October 1, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT), an innovator of novel genetic engineering of animals for creation of human therapeutic antibodies, today announced an alliance with Genmab A/S (OMX: GEN), a biotechnology...

October 1, 2014

BALTIMORE--(BUSINESS WIRE)--GVN launches Business Leadership Council, a unique initiative to engage corporate executives and business leaders in the fight against pandemic viral threats.

October 1, 2014

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced that it has opened six new clinical trials in 2014, and is on track to open more multiple myeloma clinical trials during 2014.

October 1, 2014

BOSTON--(BUSINESS WIRE)--On September 30, 2014, H&Q Life Sciences Investors paid a quarterly stock distribution of $0.45 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of...

October 1, 2014

BOSTON--(BUSINESS WIRE)--On September 30, 2014, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition...

October 1, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that 25 abstracts...

October 1, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Third Quarter on October 24

October 1, 2014

FAIRFIELD, N.J.--(BUSINESS WIRE)--The Healthcare Businesswomen's Association (HBA) has named Baxter International’s Baxter Women Leaders (BWL) business resource group as the winner of the 2014 HBA ACE award. HBA created the award to recognize...

October 1, 2014

TOULOUSE, France--(BUSINESS WIRE)--AMATSIGROUP, a dedicated service provider in both human and veterinary drug development sectors, announces the establishment of an operation site in the US in Terre Haute (Indiana).

October 1, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) and its subsidiary LifeMap Solutions, Inc., a medical technology company, today announced significant additions to the LifeMap Solutions management team. LifeMap Solutions is...

October 1, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Gil Yosipovitch, M.D. joins Clinical Advisory Board at Trevi Therapeutics.

October 1, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero...

October 1, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2014 before the market opens on Wednesday, October 22,...

October 1, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) will host a conference call and live audio webcast on Thursday, October 23, 2014 at 9 a.m. ET to discuss third quarter 2014 financial and operational results. The webcast can be...

October 1, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides has started IND-enabling safety/Toxicology studies of its Injectable FluCide(tm) drug candidate at BASi. The Company has also started making drug candidates for evaluation against Ebola.

October 1, 2014

PERKASIE, Pa.--(BUSINESS WIRE)--Chris Glasby, Senior Manufacturing Engineer at Secant Medical, will present “Existing Textile Technology Matched with Material Innovation” during the medical track at the IFAI Advanced Textiles Expo.

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company today announced the recipients of the 2014 Genzyme Patient Advocacy Leadership (PAL) Awards.

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators from the American Porphyria Consortium and The European Porphyria Network have initiated the EXPLORE trial, a...

October 1, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that the company...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma to host and webcast an online educational seminar on beta-thalassemia. Company is conducting phase 2 clinical trials of sotatercept and luspatercept in patients with the disease.

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced, in conjunction with its...

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Stemedica Cell Technologies, Inc. was issued a new patent from the U.S. Patent & Trademark Office entitled “Composition of Stem Cells and Stem Cell Factors for Their Use and Manufacture.”

October 1, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today disclosed results from recent studies further confirming CGEN-15049 as a promising target candidate for cancer immunotherapy

October 1, 2014

FAIRFAX, Va.--(BUSINESS WIRE)--ICF wins new $12 million contract with CDC to provide support for multiple aspects of CDC's BioSense program.

October 1, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Audentes Therapeutics announces the continued expansion of its management team, including the appointment of John T. Gray as Vice President, Research and Development

October 1, 2014

DALLAS--(BUSINESS WIRE)--MD Buyline released the results of the Q3.2014 “User Satisfaction Trending™” survey to MD Buyline members. Half of the nation’s hospitals rely on this information to make informed, evidence-based decisions on healthcare...

October 1, 2014

TOKYO--(BUSINESS WIRE)--Tokyo Electron Limited (TEL) opened, through its European subsidiary Tokyo Electron Europe Limited (TEE), the company’s open innovation centre at Stevenage Bioscience Catalyst (SBC) in the United Kingdom. The goal is to...

October 1, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--The public exhibition (Longyan Station) of the ‘China (Zhangjiajie) Giant Salamander’ was held in Sunrise City Mall, Longyan, Fujian Province, China from 19 September to 21 September 2014. It was co-organized...